Table 2.
GMDR models of high-order gene-environment interaction in CYP11B2 promoter on EH risk.
| Model | Training balanced accuracy | Testing balanced accuracy | Sign test (P) | Cross-validation consistency |
|---|---|---|---|---|
| CpG2 | 0.56 | 0.45 | 3 (0.945) | 6/10 |
| CpG3, smoking | 0.61 | 0.52 | 7 (0.172) | 6/10 |
| CpG1, CpG3, drinking | 0.64 | 0.49 | 5 (0.623) | 5/10 |
| CpG1, CpG3, CpG4, smoking | 0.68 | 0.60 | 9 (0.011) | 10/10 |
| CpG1, CpG3, CpG4, smoking, drinking | 0.72 | 0.53 | 7 (0.172) | 8/10 |
| CpG1, CpG2, CpG3, CpG4, smoking, drinking | 0.75 | 0.51 | 6 (0.377) | 10/10 |
P value was adjusted for age, gender, BMI, triglycerides, HDL, BUA, and Hcy using logistic regression in GMDR analysis.
GMDR: generalized multifactor dimensionality reduction; BMI: body mass index; TG: triglycerides; HDL: high-density lipoprotein; BUA: blood uric acid; Hcy: homocysteine.